ELX LEAD trial investor presentation
Filed with ASX · · 18 pages · English
In the deck
Earlier from Nova Eye Medical
- ELX FY18 ASX Release & Investor Presentation
- Trading Update for Year Ended 30th June 2018
- Glaucoma Business FY18Q3 Sales Update
- S&P DJ Indices Announces March Quarterly Rebalance
- Half Year Accounts for 31 December 2017
Later from Nova Eye Medical
- Ellex 2RT Sales & Marketing Initiatives at AAO
- 2018 CEO AGM Presentation
- Sales Update at AGM
- Investor Presentation FY2019 H1
- LiGHT Trial Shows SLT More Effective
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical